(Q44618739)

4 December 2017

title

Anti-inflammatory cytokine response and the development of multiple organ failure in severe sepsis (English)

1 reference

4 December 2017

1 reference

Loisa P

1

1 reference

4 December 2017

Rinne T

2

1 reference

4 December 2017

Laine S

3

1 reference

4 December 2017

Hurme M

4

1 reference

4 December 2017

Kaukinen S

5

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Acta Anaesthesiologica Scandinavica

4 December 2017

published in

1 reference

4 December 2017

volume

47

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

319-325

1 reference

Role of cytokines in sepsis.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Serum Cytokine Levels in Human Septic Shock

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Production of interleukin-1-receptor antagonist during experimental endotoxaemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Interleukin-10 production during septicaemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

1 reference

7 January 2021

Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

APACHE II: a severity of disease classification system

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Serum levels of interleukin-6 and acute phase responses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Interleukin 10 protects mice from lethal endotoxemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

Anti-inflammatory cytokine response and clinical outcome in acute pancreatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2003.00004.X

7 January 2021

10.1034/J.1399-6576.2003.00004.X

Identifiers

DOI

1 reference

4 December 2017

1 reference